Bridge Creek Capital Management LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 1.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 43,673 shares of the pharmacy operator’s stock after buying an additional 635 shares during the period. CVS Health Corporation accounts for about 1.9% of Bridge Creek Capital Management LLC’s holdings, making the stock its 18th largest position. Bridge Creek Capital Management LLC’s holdings in CVS Health Corporation were worth $3,514,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Mercer Capital Advisers Inc. acquired a new position in shares of CVS Health Corporation during the first quarter worth approximately $118,000. Gemmer Asset Management LLC boosted its position in shares of CVS Health Corporation by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after buying an additional 200 shares in the last quarter. Orrstown Financial Services Inc. boosted its position in shares of CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock worth $165,000 after buying an additional 2,000 shares in the last quarter. SRS Capital Advisors Inc. boosted its position in shares of CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after buying an additional 734 shares in the last quarter. Finally, Nadler Financial Group Inc. acquired a new position in shares of CVS Health Corporation during the second quarter worth approximately $202,000. Institutional investors and hedge funds own 81.92% of the company’s stock.

CVS Health Corporation (NYSE CVS) traded up 0.4493% during mid-day trading on Friday, reaching $79.4956. 1,491,417 shares of the company’s stock were exchanged. The firm has a market cap of $80.81 billion, a price-to-earnings ratio of 15.8358 and a beta of 0.91. The stock has a 50-day moving average of $78.77 and a 200-day moving average of $78.97. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $98.44.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The company had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same period in the prior year, the company posted $1.32 earnings per share. CVS Health Corporation’s revenue for the quarter was up 4.5% compared to the same quarter last year. Analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s payout ratio is 39.92%.

COPYRIGHT VIOLATION WARNING: “Bridge Creek Capital Management LLC Increases Position in CVS Health Corporation (NYSE:CVS)” was published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/11/bridge-creek-capital-management-llc-increases-position-in-cvs-health-corporation-nysecvs.html.

CVS has been the subject of a number of analyst reports. Tigress Financial initiated coverage on shares of CVS Health Corporation in a research note on Thursday, April 27th. They set a “buy” rating for the company. Vetr cut shares of CVS Health Corporation from a “buy” rating to a “hold” rating and set a $85.78 price target for the company. in a research note on Thursday, April 27th. Evercore ISI restated an “outperform” rating and set a $88.00 price target (up previously from $87.00) on shares of CVS Health Corporation in a research note on Wednesday, May 3rd. ValuEngine cut shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $82.00 price objective on shares of CVS Health Corporation in a report on Friday, June 9th. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. CVS Health Corporation has an average rating of “Buy” and an average price target of $91.27.

In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the sale, the executive vice president now directly owns 59,300 shares in the company, valued at $4,564,914. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the sale, the chief financial officer now owns 176,983 shares of the company’s stock, valued at $14,158,640. The disclosure for this sale can be found here. Insiders sold 271,175 shares of company stock valued at $21,632,597 over the last 90 days. Corporate insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.